Discontinued — last reported Q3 '25
Operating
Impairment Charges
Year-over-year, this metric declined by 100.0%, from $92.75M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2014
Last reportedQ3 2025
How to read this metric
An increase signals potential operational issues, poor past investment decisions, or adverse market conditions for specific business units.
Detailed definition
These are non-cash charges recorded when the carrying value of an asset exceeds its fair market value. They indicate tha...
Peer comparison
Often seen during restructuring or economic downturns across industrial sectors.
Metric ID:
impairment_charges_cfHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $515.00M | $0.00 | $371.00M | $0.00 |
| YoY Change | — | — | -100.0% | — | -100.0% |
Range$0.00 – $515.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Business Segments
| Segment | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Medical Surgical | — | $61.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Neuroscience | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $128.75M | $0.00 | $0.00 | $0.00 | $92.75M | $92.75M | $92.75M | $92.75M |
Neuroscience is derived from annual filings.
Medical Surgical, Neuroscience were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Medtronic's impairment charges?
- Medtronic (MDT) reported impairment charges of $0.00 in Q1 2025.
- How has Medtronic's impairment charges changed year-over-year?
- Medtronic's impairment charges decreased by 100.0% year-over-year, from $92.75M to $0.00.
- What does impairment charges mean?
- A write-down of an asset's value because it is worth less than what is recorded on the balance sheet.